Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and sucralfate powder spray for lower gastrointestinal bleeding
NCT07679139Not yet recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2027
01
Overview
Randomised, open-label trial of tranexamic acid and sucralfate in lower gastrointestinal bleeding (LGIB) (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Rebleeding within 28 days. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
tranexamic acidsucralfate
03
Conditions
lower gastrointestinal bleeding (LGIB)
Beyond the preview
Go deeper on NCT07679139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07679139.